Agenus

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Agenus" – news · newspapers · books · scholar · JSTOR (July 2022) (Learn how and when to remove this message)

Agenus Inc.

Company type	Public
Traded as	Nasdaq: AGEN Russell 2000 Component
Industry	Biotechnology Pharmaceutical Company
Founded	1994; 30 years ago (1994)
Founders	Garo H. Armen, Pramod K. Srivastava
Headquarters	3 Forbes Road, Lexington, Massachusetts, USA
Key people	Garo H. Armen (chairman and CEO) Jennifer Buell (president and COO)
Website	www.agenusbio.com

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants desugned for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.^[1]